Study of the impact of non-compliance with GINA recommendations on the care consumption of adult asthmatic patient

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/15436
• EU PAS number:
  EUPAS5309
• Study ID:
  15436
• Official title and acronym:
  Study of the impact of non-compliance with GINA recommendations on the care consumption of adult asthmatic patient
• DARWIN EU® study:
  No
• Study countries:
  France
• Study description:
  Asthma is a chronic disease that has major implications not only in terms of morbidity and mortality or of deterioration in the quality of life for patients, but also in terms of costs associated with the disease.The management of persistent asthma (GINA 2, 3 and 4) is mainly based on the trigger eviction and on drug therapy. In current medical practice, asthma remains generally under-diagnosed, under-treated and poorly controlled yet.Based on the French national health insurance database (EGB), which contains healthcare reimbursement data of 1/97 of the French population, this study aims to better understand the impact of non-compliance with GINA therapeutic recommendations on healthcare use and on absenteeism of persistent asthmatic patients. It also identifies the characteristics of patients whose care is not in accordance with these recommendations and tests the economic impact of medical nomadism on the management of asthma in 2007 and 2008.
• Study status:
  Finalised

Research institution and networks

Institutions

Université Claude Bernard Lyon 1

Study timelines

Date when funding contract was signed

Actual: 30/06/2009

Study start date

Actual: 30/10/2009

Date of final study report

Actual: 31/03/2011

Sources of funding

Other

More details on funding

CNAMTS

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable